CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (NYSE-AMEX: PLX), today announced that the Company will be presenting at the Canaccord Adams Global Growth Conference, BioCentury’s NewsMakers in the Biotech Industry Conference, and the UBS Global Life Sciences Conference.
